|
Bulk APIs |
|
Amiodarone Hydrochloride [19774-82-4] (IP, EP, BP, USP) |
Homatropine Methylbromide [80-49-9 ] (EP, BP, USP) |
|
Homatropine Hydrobromide [51-56-9 ] (EP, BP, USP) |
Ketorolac Tromethamine [74103-07-4] (EP, BP, USP) |
|
Tramadol Hydrochloride [36282-47-0 ] ( EP, BP) |
Sertraline Hydrochloride [79559-97-0 ] (EP) (Contract manufacturing) |
|
Venlafaxine Hydrochloride [99300-78-4] (EP, BP) (Contract
manufacturing) |
Ofloxacin [82419-36-1] (EP, USP, BP) (Contract manufacturing) |
|
Levofloxacin Hemihydrate [100986-85-4] (IHS) |
Metformin Hydrochloride [1115-70-4] (IP, EP, BP, USP) |
|
Clopidogrel Bisulfate, Form II [120202-66-6] (USP) |
Rabeprazole Sodium [117976-90-6] (IP & IHS) |
|
New Introductions |
|
Valsartan [137862-53-4] (USP) |
Clarithromycin [ 81103-11-9 ] ( EP, BP, USP) |
|
Dex Ketoprofen Trometamol [156604-79-4] ( IHS) |
S-Etodolac [87249-11-4] (( IHS) |
|
Fenofibrate [49562-28-9] ( EP, BP, USP) |
|
|
Under Development |
|
Donepezil Hydrochloride [120011-70-3] (IHS) |
Celecoxib [194044-54-7] |
|
Solifenacin Succinate [242478-38-2] (IHS) |
S-Rabeprazole Sodium [171440-19-0] |
|
S-Amlodipine Maleate [103188-91-6] |
Telmesartan [485391-74-0] |
|
Candesartan cilexetil [145040-37-5] |
Prasugrel [583-39-1] |
|
Advanced Intermediates |
|
Valsartan
5-(4-Bromomethyl-1,1’-biphenyl-2-yl)-1-triphenylmethyl-1h-tetrazole
[124750-51-2]
L-Valine Benzyl Ester Hydrochloride [2462-34-2]
L-Valine Benzyl Ester P-Toluene Sulphonate [16652-76-9]
L-Valine Methyl Ester Hydrochloride [6306-52-1] |
Lisinopril
L-Proline benzyl ester hydrochloride [16652-71-4]
|
|
Ketorolac Tromethamine
Ketorolac [74103-06-3] |
|
|
Cephalosporin and Carbapenem Intermediates: |
|
4-Nitrobenzyl Diazoacetoacetate [82551-63-1] for Imipenem |
Mono 4-Nitrobenzyl Malonate [77359-11-6] for Meropenem |
|
(z)-4-Bromo-2-methoxyimino-3-oxobutyric acid [79232-66-9] [Bromo
Acid] for Cefpodoxime Proxetil etc. |
(z)-4-Chloro-2-methoxyimino-3-oxobutyric acid [111230-59-2][Chloro
Acid] for Cefpodoxime Proxetil etc. |
|
1-Acetoxyethyl Bromide [40258-78-4] for Cefuroxime Axetil |
4-Nitrobenzyl Bromide [100-11-8] for Cefaclor |
|
4-Nitro Benzyl Alcohol [619-73-8] for Carbapenems |
|
|
Other Intermediates |
|
5-Chloro Salicylamide [7120-43-6] |
4-Nitrobenzaldehyde [555-16-8] |
|
Benzyl Chloroacetate [140-18-1] |
2-Phenylacetamide [103-81-1] |
|
Triphenyl Phosphonium Bromide (TPP. HBr) [6399-81-1] |
|
| |
|
|
Products protected by valid patents are not offered
for sale in countries where the sale of such
products constitutes a patent infringement and its
liability is at buyer's risk |
